Rankings
Pricing
Log In
Free Trial
US-listed companies
Vor Biopharma Inc.
Vor Biopharma Inc.
VOR
Market cap
$45.52M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2021
Dec 31,
2022
Cash and cash equivalents
120
58
Marketable securities
88
173
Prepaid expenses
5
4
Other current assets
2
2
Total current assets
214
237
Restricted cash equivalents
2
2
Property and equipment, net
7
13
Operating lease right-of-use assets
16
44
Other assets
3
3
Total assets
243
299
Accounts payable
2
2
Accrued liabilities
6
8
Operating lease liabilities
2
3
Other current liabilities
0
0
Total current liabilities
10
13
Operating Lease, Liability, Noncurrent
16
36
Total liabilities
26
49
Common Stock, Value, Issued
0
0
Additional paid-in capital
346
474
Accumulated other comprehensive loss
-
-1
Accumulated deficit
-130
-222
Total stockholders' equity
216
251
Total liabilities and stockholders equity
243
299